These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19844733)

  • 1. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
    Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis.
    Okazaki S; Ogawa F; Iwata Y; Hara T; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Rheumatol Int; 2010 May; 30(7):871-8. PubMed ID: 19639321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
    Ogawa F; Shimizu K; Muroi E; Hara T; Hasegawa M; Takehara K; Sato S
    Rheumatology (Oxford); 2006 Jul; 45(7):815-8. PubMed ID: 16449367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Hasegawa M; Takehara K; Sato S
    Clin Exp Rheumatol; 2008; 26(4):659-62. PubMed ID: 18799101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.
    Sato S; Hayakawa I; Hasegawa M; Fujimoto M; Takehara K
    J Invest Dermatol; 2003 Apr; 120(4):542-7. PubMed ID: 12648215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
    Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
    Front Immunol; 2021; 12():686483. PubMed ID: 34276673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
    Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
    Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody against a protease domain of caspase-8 in patients with systemic sclerosis.
    Yamaoka T; Ogawa F; Muroi E; Hara T; Komura K; Iwata Y; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Clin Exp Rheumatol; 2008; 26(6):998-1004. PubMed ID: 19210862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
    Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.
    Ihn H; Sato S; Fujimoto M; Igarashi A; Yazawa N; Kubo M; Kikuchi K; Takehara K; Tamaki K
    Clin Exp Immunol; 2000 Jan; 119(1):203-9. PubMed ID: 10606984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.